Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.

Zignol M, Dean AS, Alikhanova N, Andres S, Cabibbe AM, Cirillo DM, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Husain A, Hussain A, Ismail N, Kamal M, Mansjö M, Mvusi L, Niemann S, Omar SV, Qadeer E, Rigouts L, Ruesch-Gerdes S, Schito M, Seyfaddinova M, Skrahina A, Tahseen S, Wells WA, Mukadi YD, Kimerling M, Floyd K, Weyer K, Raviglione MC.

Lancet Infect Dis. 2016 Oct;16(10):1185-1192. doi: 10.1016/S1473-3099(16)30190-6. Epub 2016 Jul 7.

2.

Recommendations of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the Diagnosis and Treatment of Non-tuberculous Mycobacterioses.

Schoenfeld N, Haas W, Richter E, Bauer T, Boes L, Castell S, Hauer B, Magdorf K, Matthiessen W, Mauch H, Reuss A, Schenkel K, Ruesch-Gerdes S, Zabel P, Dalhoff K, Schaberg T, Loddenkemper R.

Pneumologie. 2016 Apr;70(4):250-76. doi: 10.1055/s-0041-111494. Epub 2016 Apr 11. Review.

PMID:
27064418
3.

External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study.

Nikolayevskyy V, Hillemann D, Richter E, Ahmed N, van der Werf MJ, Kodmon C, Drobniewski F, Ruesch-Gerdes S; ERLTB-Net Network.

PLoS One. 2016 Apr 7;11(4):e0152926. doi: 10.1371/journal.pone.0152926. eCollection 2016.

4.

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay.

Blakemore R, Nabeta P, Davidow AL, Vadwai V, Tahirli R, Munsamy V, Nicol M, Jones M, Persing DH, Hillemann D, Ruesch-Gerdes S, Leisegang F, Zamudio C, Rodrigues C, Boehme CC, Perkins MD, Alland D.

Am J Respir Crit Care Med. 2011 Nov 1;184(9):1076-84. doi: 10.1164/rccm.201103-0536OC.

5.

Rapid molecular detection of tuberculosis and rifampin resistance.

Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD.

N Engl J Med. 2010 Sep 9;363(11):1005-15. doi: 10.1056/NEJMoa0907847. Epub 2010 Sep 1.

6.

Unequal distribution of resistance-conferring mutations among Mycobacterium tuberculosis and Mycobacterium africanum strains from Ghana.

Homolka S, Meyer CG, Hillemann D, Owusu-Dabo E, Adjei O, Horstmann RD, Browne EN, Chinbuah A, Osei I, Gyapong J, Kubica T, Ruesch-Gerdes S, Niemann S.

Int J Med Microbiol. 2010 Nov;300(7):489-95. doi: 10.1016/j.ijmm.2010.04.019. Epub 2010 Jun 9.

PMID:
20538518
7.

Epidemiology and clinical management of XDR-TB: a systematic review by TBNET.

Sotgiu G, Ferrara G, Matteelli A, Richardson MD, Centis R, Ruesch-Gerdes S, Toungoussova O, Zellweger JP, Spanevello A, Cirillo D, Lange C, Migliori GB.

Eur Respir J. 2009 Apr;33(4):871-81. doi: 10.1183/09031936.00168008. Epub 2009 Feb 27. Review.

8.

Multidrug- and extensively drug-resistant tuberculosis, Germany.

Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C; German TBNET Group.

Emerg Infect Dis. 2008 Nov;14(11):1700-6. doi: 10.3201/eid1411.080729.

9.

Mycobacterium tuberculosis drug resistance, Ghana.

Owusu-Dabo E, Adjei O, Meyer CG, Horstmann RD, Enimil A, Kruppa TF, Bonsu F, Browne EN, Chinbuah MA, Osei I, Gyapong J, Berberich C, Kubica T, Niemann S, Ruesch-Gerdes S.

Emerg Infect Dis. 2006 Jul;12(7):1171-2. No abstract available.

10.

Multidrug-resistant tuberculosis in central Asia.

Cox HS, Orozco JD, Male R, Ruesch-Gerdes S, Falzon D, Small I, Doshetov D, Kebede Y, Aziz M.

Emerg Infect Dis. 2004 May;10(5):865-72.

11.

Description of Mycobacterium heckeshornense sp. nov.

Richter E, Niemann S, Ruesch-Gerdes S, Harmsen D.

J Clin Microbiol. 2001 Aug;39(8):3023-4. No abstract available.

12.

Clinical course of human immunodeficiency virus type 1 associated pulmonary tuberculosis during short-course antituberculosis therapy.

Schwander SK, Dietrich M, Mugyenyi P, Kityo C, Okwera A, Johnson J, Nsubuga P, Ruesch-Gerdes S, Whalen C.

East Afr Med J. 1997 Sep;74(9):543-8.

PMID:
9487427

Supplemental Content

Loading ...
Support Center